Results of interstitial radiation therapy with iridium-192 for patients with carcinoma of the oral tongue

Abstract

Between 1973 and 1985, 286 patients with squamous cell carcinoma of the oral tongue (T1NO: 72; T2NO: 180; T3NO: 34) were treated with Iridium-192 interstitial irradiation at the Department of Radiology, Osaka University Hospital. Five-year control rates of the primary lesion by Iridium-192 implant alone or in combination with external irradiation was 70% (T1: 77%; T2: 71%; T3: 47%), and ultimate local control rate after salvage surgery only for recurrence was 85% (T1: 93%; T2: 87%; T3: 62%). These results are comparable to those obtained by interstitial therapy with radium needles, with the superior advantage of lower risk to the medical staff.

DOI: 10.1007/BF02348954

9 Figures and Tables

Cite this paper

@article{Masaki2006ResultsOI, title={Results of interstitial radiation therapy with iridium-192 for patients with carcinoma of the oral tongue}, author={Ph.D. Norie Masaki and Ph.D. Hiroshi Ikeda and Kinji Nishiyama and T Inoue and Ph.D. Takahiro Kozuka and Ph.D. Kimishige Shimizutani and Ph.D. Souhei Furukawa and Ph.D. Kazuko Kubo and Ph.D. Hajime Fuchihata}, journal={Oral Radiology}, year={2006}, volume={4}, pages={23-29} }